Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 17 04:00PM ET
1.39
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-4.36 Insider Own36.83% Shs Outstand5.37M Perf Week2.51%
Market Cap9.15M Forward P/E- EPS next Y-3.82 Insider Trans11.50% Shs Float4.16M Perf Month6.51%
Income-18.40M PEG- EPS next Q-1.44 Inst Own40.53% Short Float3.08% Perf Quarter-16.27%
Sales31.76M P/S0.29 EPS this Y-90.56% Inst Trans-24.36% Short Ratio2.79 Perf Half Y-61.71%
Book/sh1.09 P/B1.27 EPS next Y-11.37% ROA-34.83% Short Interest0.13M Perf Year-81.20%
Cash/sh1.03 P/C1.35 EPS next 5Y3.20% ROE-929.14% 52W Range1.01 - 9.45 Perf YTD-62.73%
Dividend Est.- P/FCF- EPS past 5Y34.83% ROI-123.10% 52W High-85.29% Beta1.23
Dividend TTM- Quick Ratio1.25 Sales past 5Y59.75% Gross Margin81.32% 52W Low37.62% ATR (14)0.12
Dividend Ex-Date- Current Ratio1.25 EPS Y/Y TTM72.97% Oper. Margin-70.21% RSI (14)58.57 Volatility9.37% 9.57%
Employees62 Debt/Eq1.98 Sales Y/Y TTM-33.68% Profit Margin-57.92% Recom1.00 Target Price18.00
Option/ShortNo / Yes LT Debt/Eq1.55 EPS Q/Q-97.18% Payout- Rel Volume0.41 Prev Close1.39
Sales Surprise87.99% EPS Surprise110.26% Sales Q/Q-69.73% EarningsMay 15 AMC Avg Volume45.92K Price1.39
SMA2013.58% SMA505.69% SMA200-57.74% Trades Volume18,880 Change0.00%
Date Action Analyst Rating Change Price Target Change
Apr-21-21Initiated BofA Securities Buy $12
Feb-01-21Initiated UBS Neutral $13
Sep-08-20Initiated Jefferies Buy $21
Mar-25-20Initiated Stifel Buy $19
Feb-27-20Initiated Barclays Overweight $22
Apr-29-19Initiated UBS Buy $12
Dec-11-18Initiated Oppenheimer Outperform $15
Oct-08-18Initiated Laidlaw Buy $18
Jun-21-24 07:30AM
Jun-03-24 08:11AM
May-30-24 07:47AM
May-15-24 11:53PM
05:11PM
01:52PM Loading…
Apr-11-24 01:52PM
Apr-09-24 08:11AM
Mar-29-24 08:21AM
Mar-28-24 08:11AM
Mar-04-24 08:11AM
Feb-08-24 05:55PM
Nov-13-23 04:11PM
Nov-02-23 04:11PM
Nov-01-23 04:12PM
Sep-28-23 04:11PM
08:50AM Loading…
Aug-25-23 08:50AM
Aug-11-23 11:22AM
Aug-10-23 08:08AM
Aug-04-23 09:16AM
Aug-02-23 04:11PM
Jul-20-23 06:55AM
Jul-13-23 08:14AM
Jun-16-23 08:56PM
Jun-01-23 07:57AM
May-26-23 05:10PM
May-15-23 04:13PM
May-04-23 10:00AM
Apr-17-23 08:00AM
Apr-07-23 06:50PM
Mar-30-23 07:25PM
06:10PM Loading…
06:10PM
Mar-09-23 10:02AM
Mar-01-23 04:44PM
Dec-02-22 05:02PM
Nov-23-22 04:30PM
Nov-13-22 07:39AM
Nov-10-22 05:55PM
04:15PM
Nov-04-22 11:00AM
Aug-31-22 04:52PM
Aug-17-22 06:17AM
Aug-11-22 04:10PM
Aug-08-22 10:00AM
Aug-04-22 10:00AM
Jun-06-22 08:00AM
May-17-22 04:05PM
May-12-22 04:30PM
May-10-22 05:25PM
May-06-22 10:18AM
May-05-22 05:55PM
03:00PM
May-04-22 07:25AM
Apr-12-22 07:30AM
Apr-08-22 08:00AM
Mar-28-22 04:30PM
Mar-18-22 12:39PM
Mar-02-22 08:00AM
Mar-01-22 08:00AM
Jan-17-22 07:08AM
Nov-30-21 05:30PM
Nov-18-21 08:00AM
Nov-16-21 09:06AM
Nov-15-21 12:25PM
07:30AM
Oct-28-21 03:05PM
12:31PM
Oct-12-21 09:08AM
Sep-22-21 03:24AM
Sep-20-21 08:00AM
Sep-14-21 12:09PM
Aug-12-21 08:05PM
04:30PM
Aug-05-21 10:50AM
Jul-29-21 03:05PM
Jul-21-21 03:20PM
Jul-19-21 05:27AM
Jul-09-21 08:00AM
Jul-06-21 08:00AM
Jun-30-21 08:30AM
May-18-21 03:04AM
May-13-21 07:50PM
04:30PM
Apr-20-21 11:36AM
Apr-12-21 07:00AM
Apr-05-21 04:12PM
11:48AM
07:00AM
Mar-21-21 03:37AM
Mar-18-21 04:30PM
Feb-26-21 08:00AM
Feb-21-21 03:02AM
Feb-18-21 07:30AM
Feb-17-21 04:05PM
Feb-11-21 09:13AM
07:30AM
Feb-08-21 06:20AM
Jan-19-21 08:00AM
Dec-21-20 04:30PM
Dec-18-20 10:21PM
Nov-30-20 09:54PM
Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariepy, and Leigh Revers in 2001 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BIOTECH TARGET N V10% OwnerApr 02 '24Buy2.35250,000587,5001,279,820Apr 04 08:13 PM